Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0010494 | cytoplasmic stress granule | 5 | 1 |
GO:0016281 | eukaryotic translation initiation factor 4F complex | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0035770 | ribonucleoprotein granule | 3 | 1 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0099080 | supramolecular complex | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HGV2
Term | Name | Level | Count |
---|---|---|---|
GO:0006413 | translational initiation | 3 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0003723 | RNA binding | 4 | 10 |
GO:0003743 | translation initiation factor activity | 4 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0008135 | translation factor activity, RNA binding | 3 | 10 |
GO:0045182 | translation regulator activity | 1 | 10 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
GO:0000339 | RNA cap binding | 5 | 1 |
GO:0000340 | RNA 7-methylguanosine cap binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 297 | 301 | PF00656 | 0.439 |
CLV_NRD_NRD_1 | 204 | 206 | PF00675 | 0.299 |
CLV_PCSK_SKI1_1 | 206 | 210 | PF00082 | 0.358 |
CLV_PCSK_SKI1_1 | 238 | 242 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 275 | 279 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 299 | 303 | PF00082 | 0.259 |
CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.598 |
DEG_APCC_DBOX_1 | 298 | 306 | PF00400 | 0.497 |
DEG_MDM2_SWIB_1 | 182 | 189 | PF02201 | 0.497 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.651 |
DOC_CKS1_1 | 189 | 194 | PF01111 | 0.439 |
DOC_MAPK_gen_1 | 216 | 225 | PF00069 | 0.497 |
DOC_MAPK_gen_1 | 270 | 279 | PF00069 | 0.502 |
DOC_MAPK_HePTP_8 | 269 | 281 | PF00069 | 0.580 |
DOC_MAPK_JIP1_4 | 275 | 281 | PF00069 | 0.540 |
DOC_MAPK_MEF2A_6 | 218 | 227 | PF00069 | 0.515 |
DOC_MAPK_MEF2A_6 | 272 | 281 | PF00069 | 0.573 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.685 |
DOC_USP7_MATH_1 | 132 | 136 | PF00917 | 0.679 |
DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.552 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.738 |
DOC_USP7_MATH_1 | 190 | 194 | PF00917 | 0.552 |
DOC_USP7_MATH_1 | 325 | 329 | PF00917 | 0.599 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.758 |
DOC_USP7_UBL2_3 | 12 | 16 | PF12436 | 0.771 |
DOC_USP7_UBL2_3 | 309 | 313 | PF12436 | 0.497 |
DOC_USP7_UBL2_3 | 334 | 338 | PF12436 | 0.639 |
DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.522 |
DOC_WW_Pin1_4 | 17 | 22 | PF00397 | 0.569 |
DOC_WW_Pin1_4 | 188 | 193 | PF00397 | 0.439 |
DOC_WW_Pin1_4 | 337 | 342 | PF00397 | 0.531 |
DOC_WW_Pin1_4 | 54 | 59 | PF00397 | 0.676 |
LIG_14-3-3_CanoR_1 | 232 | 241 | PF00244 | 0.552 |
LIG_deltaCOP1_diTrp_1 | 180 | 186 | PF00928 | 0.497 |
LIG_FHA_1 | 220 | 226 | PF00498 | 0.499 |
LIG_FHA_1 | 276 | 282 | PF00498 | 0.581 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.584 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.591 |
LIG_LIR_Apic_2 | 211 | 215 | PF02991 | 0.580 |
LIG_LIR_Gen_1 | 200 | 208 | PF02991 | 0.499 |
LIG_LIR_Gen_1 | 242 | 253 | PF02991 | 0.499 |
LIG_LIR_Nem_3 | 142 | 146 | PF02991 | 0.517 |
LIG_LIR_Nem_3 | 165 | 171 | PF02991 | 0.573 |
LIG_LIR_Nem_3 | 180 | 185 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 200 | 204 | PF02991 | 0.405 |
LIG_PAM2_1 | 37 | 49 | PF00658 | 0.631 |
LIG_Pex14_1 | 203 | 207 | PF04695 | 0.439 |
LIG_Pex14_2 | 168 | 172 | PF04695 | 0.543 |
LIG_Pex14_2 | 182 | 186 | PF04695 | 0.449 |
LIG_SH2_PTP2 | 207 | 210 | PF00017 | 0.439 |
LIG_SH2_STAP1 | 199 | 203 | PF00017 | 0.638 |
LIG_SH2_STAT5 | 188 | 191 | PF00017 | 0.515 |
LIG_SH2_STAT5 | 199 | 202 | PF00017 | 0.515 |
LIG_SH2_STAT5 | 207 | 210 | PF00017 | 0.515 |
LIG_SH3_3 | 24 | 30 | PF00018 | 0.783 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.628 |
LIG_SH3_3 | 71 | 77 | PF00018 | 0.654 |
LIG_SUMO_SIM_anti_2 | 222 | 227 | PF11976 | 0.540 |
LIG_SUMO_SIM_par_1 | 222 | 229 | PF11976 | 0.459 |
LIG_SxIP_EBH_1 | 131 | 143 | PF03271 | 0.540 |
LIG_WRC_WIRS_1 | 179 | 184 | PF05994 | 0.640 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.571 |
MOD_CK1_1 | 160 | 166 | PF00069 | 0.591 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.567 |
MOD_CK1_1 | 233 | 239 | PF00069 | 0.591 |
MOD_CK1_1 | 80 | 86 | PF00069 | 0.665 |
MOD_CK2_1 | 174 | 180 | PF00069 | 0.439 |
MOD_CK2_1 | 253 | 259 | PF00069 | 0.497 |
MOD_CMANNOS | 183 | 186 | PF00535 | 0.297 |
MOD_GlcNHglycan | 113 | 117 | PF01048 | 0.449 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.556 |
MOD_GlcNHglycan | 192 | 195 | PF01048 | 0.340 |
MOD_GlcNHglycan | 231 | 235 | PF01048 | 0.380 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.718 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.797 |
MOD_GlcNHglycan | 39 | 42 | PF01048 | 0.711 |
MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.811 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.738 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.583 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.585 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.572 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.528 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.740 |
MOD_GSK3_1 | 337 | 344 | PF00069 | 0.506 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.756 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.733 |
MOD_N-GLC_1 | 174 | 179 | PF02516 | 0.258 |
MOD_NEK2_1 | 294 | 299 | PF00069 | 0.497 |
MOD_PIKK_1 | 98 | 104 | PF00454 | 0.662 |
MOD_Plk_1 | 325 | 331 | PF00069 | 0.442 |
MOD_Plk_1 | 98 | 104 | PF00069 | 0.635 |
MOD_Plk_4 | 178 | 184 | PF00069 | 0.586 |
MOD_Plk_4 | 194 | 200 | PF00069 | 0.442 |
MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.522 |
MOD_ProDKin_1 | 17 | 23 | PF00069 | 0.572 |
MOD_ProDKin_1 | 188 | 194 | PF00069 | 0.439 |
MOD_ProDKin_1 | 337 | 343 | PF00069 | 0.526 |
MOD_ProDKin_1 | 54 | 60 | PF00069 | 0.676 |
MOD_SUMO_for_1 | 15 | 18 | PF00179 | 0.666 |
MOD_SUMO_for_1 | 208 | 211 | PF00179 | 0.552 |
MOD_SUMO_for_1 | 91 | 94 | PF00179 | 0.730 |
MOD_SUMO_rev_2 | 68 | 73 | PF00179 | 0.665 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.497 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3S7 | Leptomonas seymouri | 72% | 99% |
A0A1X0NR97 | Trypanosomatidae | 50% | 72% |
A0A3Q8IDB8 | Leishmania donovani | 88% | 99% |
A0A3R7L212 | Trypanosoma rangeli | 50% | 76% |
A4I3Y2 | Leishmania infantum | 88% | 99% |
D0A951 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 78% |
E9B072 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 99% |
Q4Q813 | Leishmania major | 87% | 100% |